Present Status and Perspectives of Antibody Therapy against Cancer
-
- KUROKI Masahide
- Department of Biochemistry, Fukuoka University School of Medicine
-
- SHIBAGUCHI Hirotomo
- Department of Biochemistry, Fukuoka University School of Medicine
-
- KUROKI Motomu
- Department of Biochemistry, Fukuoka University School of Medicine
Bibliographic Information
- Other Title
-
- 抗体を利用した癌治療法の現状と新展開
- コウタイ オ リヨウ シタ ガン チリョウホウ ノ ゲンジョウ ト シン テンカイ
Search this article
Abstract
The purpose of this article is to review the current status and future perspectives of antibody therapy against cancer. Eight antibody drugs against cancer are now commercially and clinically available for treatment of cancer in the United States and two of them are also available in Japan. Current data suggest that antibodies or their genes against cancer can be used in order to increase the tumor specificity of various new immunotherapeutic or gene therapeutic approaches against cancer, thereby enhancing the tumoricidal effect of each treatment while reducing the side effects.<br>
Journal
-
- Japanese Journal of Complementary and Alternative Medicine
-
Japanese Journal of Complementary and Alternative Medicine 2 (1), 15-21, 2005
The Japanese Society for Complementary and Alternative Medicine
- Tweet
Details 詳細情報について
-
- CRID
- 1390001205220236544
-
- NII Article ID
- 130000079413
-
- NII Book ID
- AA12095429
-
- ISSN
- 13487930
- 13487922
-
- NDL BIB ID
- 7355751
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- NDL
- Crossref
- CiNii Articles
-
- Abstract License Flag
- Disallowed